BRIEF-Turnstone Biologics to Be Acquired by XOMA for $0.34/Share Plus Contingent Value Right

Reuters
27 Jun
BRIEF-Turnstone Biologics to Be Acquired by XOMA for $0.34/Share Plus Contingent Value Right

June 27 (Reuters) - Turnstone Biologics Corp TSBX.O:

  • TURNSTONE BIOLOGICS CORP. ENTERS INTO AGREEMENT TO BE ACQUIRED BY XOMA ROYALTY CORPORATION FOR $0.34 IN CASH PER SHARE PLUS A CONTINGENT VALUE RIGHT

  • TURNSTONE BIOLOGICS CORP - DEAL VALUED AT $0.34 PER SHARE PLUS CVR

Source text: ID:nGNX6hGWnv

Further company coverage: TSBX.O

((Reuters.Briefs@thomsonreuters.com;))

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10